Synairgen to delist from public market
Why we think this is neutral
This RNS announcement does not contain any of the mandatory news types required for a more detailed analysis. It appears to be a general update on the company's plans to delist from the public market.
Key Points
- Shareholders approved the adoption of new articles of association to facilitate the company's transition to a private limited company
- TFG Asset Management UK, the majority shareholder, has agreed to waive its rights over share transfers until a future equity fundraise
- The Asset Match trading facility will remain in place for a minimum of two years from the cancellation of the company's AIM listing
Summary
The respiratory company is updating shareholders on its plans to re-register as a private limited company following a recent general meeting.
Synairgen plc (LSE: SNG) has provided an update on its plans to re-register as a private limited company following a recent general meeting. The company has reached an agreement with its majority shareholder, TFG Asset Management UK, to waive certain transfer restrictions on the company's shares, allowing them to remain freely transferable until a future equity fundraise.
Key Dates
9 April 2027
Asset Match trading facility ends
GENERAL UPDATE